Penumbra Inc (PEN)
Days of sales outstanding (DSO)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | |
DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for Penumbra Inc is not provided in the financial data for the years ranging from December 31, 2020, to December 31, 2024. This prevents us from assessing the efficiency of the company in collecting its accounts receivable and its overall liquidity position. It is crucial for companies to track and manage their DSO as it indicates how quickly they are able to convert their accounts receivable into cash, thus impacting their working capital and cash flow management. Without this information, it is challenging to evaluate Penumbra Inc's performance in this aspect.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Penumbra Inc
PEN
—
3M Company
MMM
47.44
Artivion Inc
AORT
—
Baxter International Inc
BAX
—
Becton Dickinson and Company
BDX
54.86
Boston Scientific Corp
BSX
—
DexCom Inc
DXCM
—
Embecta Corp
EMBC
80.52
Glaukos Corp
GKOS
58.61
Globus Medical
GMED
—
Haemonetics Corporation
HAE
29.06